Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapacuronium: first experience in clinical practice.

R R Bartkowski1, T A Witkowski

  • 1Department of Anesthesiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA. R.Bartkowski@mail.tju.edu

European Journal of Anaesthesiology. Supplement
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances in neuromuscular blocking agents.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999
Same author

The safety and efficacy of oral transmucosal fentanyl citrate for preoperative sedation in young children.

Anesthesia and analgesia·1996
Same author

Measurement of CO2 response with the breath-by-breath automatic acquisition of the breathing pattern and occlusion pressure.

Journal of clinical monitoring·1995
Same author

Intraoperative hemodynamic, renin, and catecholamine responses after prophylactic and intraoperative administration of intravenous enalaprilat.

Anesthesia and analgesia·1995
Same author

Rocuronium onset of action: a comparison with atracurium and vecuronium.

Anesthesia and analgesia·1993
Same author

The pharmacokinetics of droperidol in anesthetized children.

Anesthesia and analgesia·1993
Same journal

EuroNeuro 2010. Abstracts of the 6th EuroNeuro Congress. Porto, Portugal. February 4-6, 2010.

European journal of anaesthesiology. Supplement·2010
Same journal

Euroanaesthesia 2003. Abstracts of the joint meeting of the European Society of Anaesthesiologists and European Academy of Anaesthesiology, Confederation of European National Societies of Anaesthesiology, and Association of Anaesthetists of Great Britain & Ireland. May 31-June 3, 2003. Glasgow, Scotland.

European journal of anaesthesiology. Supplement·2008
Same journal

Evoked potentials in the ICU.

European journal of anaesthesiology. Supplement·2008
Same journal

Intracranial pressure monitoring.

European journal of anaesthesiology. Supplement·2008
Same journal

Phrenic nerve stimulation.

European journal of anaesthesiology. Supplement·2008
Same journal

Direct stimulation: a useful technique.

European journal of anaesthesiology. Supplement·2008
See all related articles

Rapacuronium offers rapid onset and recovery, making it ideal for short outpatient procedures requiring tracheal intubation. Its use is growing, though adverse effects like bronchospasm require careful management.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Rapacuronium is a novel non-depolarizing neuromuscular relaxant.
  • Approved in the US in 1999, it offers fast onset and rapid recovery characteristics.

Purpose of the Study:

  • To review the clinical acceptance and specific applications of rapacuronium.
  • To evaluate its advantages and disadvantages compared to existing agents like succinylcholine.

Main Methods:

  • Review of clinical data and practice patterns regarding rapacuronium use.
  • Analysis of recovery times and adverse event profiles.

Main Results:

  • Rapacuronium is favored for brief outpatient procedures needing tracheal intubation.
  • Average recovery to a train-of-four ratio of 80% is approximately 25 minutes post-reversal.

Related Experiment Videos

  • Spontaneous recovery may allow for non-reversal after 30-60 minutes, verified by monitoring.

    • Conclusions:

    • Rapacuronium fills a niche for procedures requiring rapid onset and short duration.
    • Bronchospasm is the primary clinical concern; dose-related adverse effects can be minimized.
    • It presents an alternative to succinylcholine for specific outpatient and rapid termination scenarios.